Tirzepatide Weight Loss Before and After: Results and Realistic Expectations

Dr. Crystal Broussard, MD

Board Certified in Family Medicine  ·  Specialized Training in Obesity Medicine

Updated March 30, 2026

Tirzepatide Weight Loss Before and After: What Clinical Trials and Real-World Results Show

If you’re researching tirzepatide weight loss before and after results, you’re likely looking for realistic expectations, not just best-case scenarios. What can the average person expect at 3 months, 6 months, and 12 months?

The anchor study here is the NEJM SURMOUNT-1 trial, a 72-week randomized controlled trial in adults with obesity (without diabetes) that showed 15–21% average total body weight loss depending on dose. N Engl J Med 2022 With tirzepatide 5 mg weekly, participants lost an average of 15.0% of their body weight. At 10 mg, they lost 19.5%. At 15 mg, they lost 20.9%. In contrast, placebo produced only 3.1% weight loss.

Even more striking: 85–91% of patients lost at least 5% of their body weight, and 50–57% lost 20% or more. N Engl J Med 2022 These aren’t cherry-picked success stories. They’re the average outcomes in a rigorous clinical trial.

As Dr. Crystal Broussard, MD, Board Certified in Family Medicine, specializing in Obesity Medicine, I’ve seen these results translate to real-world practice when patients receive physician-supervised care with consistent monitoring and lifestyle support. This article will cover the clinical trial timeline, what influences individual variation, and how our approach at Harmony Aesthetics Spa supports long-term success.

Important Safety Information

Tirzepatide carries a boxed warning for thyroid C-cell tumors (seen in animal studies; unknown risk in humans) and should not be used by patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. FDA Prescribing Information It is contraindicated in patients with a history of serious hypersensitivity to tirzepatide.

Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal discomfort, which are generally mild to moderate and decrease over time. N Engl J Med 2022 Patients with a history of pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, or who are pregnant or breastfeeding should discuss these conditions with their physician before starting treatment. This is a prescription medication that requires medical evaluation and ongoing supervision.

How Tirzepatide Works: The Science Behind the Results

Tirzepatide is a dual GIP/GLP-1 receptor agonist. It mimics two naturally occurring hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), that regulate appetite, blood sugar, and how the body stores and uses energy. Mayo Clinic

Unlike older weight loss medications that work primarily on appetite suppression or fat absorption, tirzepatide addresses multiple metabolic pathways. It reduces hunger and cravings, slows gastric emptying (helping you feel full longer), improves insulin sensitivity, and influences how the body partitions calories between fat storage and energy use. Cleveland Clinic

This dual-action mechanism is why tirzepatide produces substantial weight loss. Research suggests tirzepatide’s dual-action approach may produce greater weight loss than single-action GLP-1 medications like semaglutide in head-to-head comparisons. The medication is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg and gradually increasing to 10 mg or 15 mg based on tolerance and response.

Tirzepatide Results Timeline: What to Expect at 3, 6, and 12 Months

First 3 Months: Initial Weight Loss and Dose Titration

Many patients begin to see weight loss within the first 4–6 weeks of starting tirzepatide. During this phase, the medication dose is gradually increased from the starting dose (2.5 mg) to the target therapeutic dose (10 mg or 15 mg), which allows the body to adjust and minimizes gastrointestinal side effects.

Patients typically notice reduced appetite, fewer cravings, and feeling satisfied with smaller portions. The SURMOUNT-1 trial showed that weight loss begins early and continues steadily as the dose increases, with the rate of loss accelerating as patients reach their maintenance dose. N Engl J Med 2022

Months 3–6: Steady Weight Loss Phase

Between months 3 and 6, patients typically experience consistent, steady weight loss as they remain on their therapeutic dose. Average cumulative weight loss at 6 months ranges from 10–15% of total body weight, depending on dose and individual factors. This is the phase where patients often see the most visible changes in body composition, clothing size, and metabolic markers like blood pressure, blood sugar, and cholesterol.

The SURMOUNT-2 trial in patients with type 2 diabetes showed similar weight loss trajectories alongside improvements in glycemic control and cardiometabolic risk factors, demonstrating that tirzepatide works effectively even in patients with metabolic disease. Lancet 2023

Months 6–12 and Beyond: Maximum Weight Loss and Maintenance

Weight loss continues through 12–18 months, with many patients reaching their maximum weight loss between 60–72 weeks. In the SURMOUNT-1 trial, average weight loss at 72 weeks was 15.0% with the 5 mg dose, 19.5% with the 10 mg dose, and 20.9% with the 15 mg dose. N Engl J Med 2022

A large percentage of patients achieved clinically significant weight loss: 89–96% lost at least 5% of body weight, 73–86% lost at least 10%, and 50–63% lost 20% or more, depending on dose. N Engl J Med 2022

The SURMOUNT-4 trial showed that continuing tirzepatide after reaching goal weight maintains or further reduces weight, while discontinuing the medication leads to significant weight regain. In that study, patients who continued tirzepatide maintained an additional 5.5% weight loss at week 88, while those who switched to placebo regained an average of 14.0% of their body weight. JAMA 2024 This underscores that tirzepatide is a long-term treatment for a chronic condition, not a short-term fix.

What Influences Individual Results: Why Some Patients Lose More Than Others

While clinical trial averages provide a helpful benchmark, individual results vary based on several factors.

Starting weight and BMI influence total pounds lost. A patient starting at 250 lbs will lose more absolute weight than a patient starting at 180 lbs, even if the percentage is similar. Adherence to the medication schedule and lifestyle modifications, including nutrition quality, physical activity, sleep, and stress management, significantly impact outcomes.

Metabolic health at baseline also matters. The SURMOUNT-2 trial showed that patients with type 2 diabetes still achieved substantial weight loss, though the presence of insulin resistance or other metabolic conditions can slow the rate of loss. Lancet 2023

Dose matters as well. The 15 mg dose consistently produced greater weight loss than the 10 mg or 5 mg doses across all trials. N Engl J Med 2022

The SURMOUNT-CN trial in Chinese adults demonstrated that tirzepatide produces clinically meaningful results across different populations, though response rates and tolerability can vary by ethnicity and genetic factors. JAMA 2024

This is why physician-supervised treatment with individualized dosing, regular monitoring, and metabolic assessment produces better outcomes than medication alone. It allows for adjustments based on how each patient responds.

Tirzepatide for Weight Loss in Spring, TX and the Greater North Houston Area

Many adults in Spring, The Woodlands, Tomball, Kingwood, and surrounding North Houston communities are managing weight alongside demanding careers, family schedules, and the metabolic effects of aging or hormonal changes.

Traditional diet-and-exercise programs often fail not because of lack of effort, but because the body’s hormonal systems resist sustained weight loss, especially after previous weight cycling or in the presence of insulin resistance, prediabetes, or fatty liver disease. Tirzepatide addresses these physiological barriers, which is why it produces results that patients haven’t been able to achieve with willpower alone. N Engl J Med 2022

At Harmony Aesthetics Spa, I provide physician-supervised tirzepatide treatment with weekly InBody body composition monitoring, which tracks not just weight but muscle mass, body fat percentage, and visceral fat. This approach supports patients in losing fat while preserving metabolically active muscle tissue, which supports long-term weight maintenance and metabolic health.

When Is It Time to Talk to Dr. Crystal About Tirzepatide?

You may be a great candidate if:

1. Your BMI is 30 or higher, or 27 or higher with a weight-related health condition like prediabetes, high blood pressure, high cholesterol, or fatty liver disease. These are the FDA-approved indications. FDA Prescribing Information

2. You’ve tried diet and exercise programs without achieving lasting results, or you’ve lost weight in the past but regained it.

3. You’re experiencing metabolic symptoms like fatigue, brain fog, joint pain, or difficulty sleeping that are connected to excess weight.

4. You’re motivated to commit to a physician-supervised program that includes lifestyle modifications alongside medication.

This isn’t about vanity or a quick fix. It’s about addressing a chronic metabolic condition with a treatment that has strong clinical evidence behind it. NIDDK

If you’re unsure whether tirzepatide is right for you, a consultation with me will include a full metabolic assessment, discussion of your weight history and health goals, and a personalized treatment plan that may include tirzepatide, lifestyle coaching, or other medical weight management approaches.

What to Expect During Tirzepatide Treatment at Harmony Aesthetics Spa

A consultation with me begins with a comprehensive metabolic assessment: medical history, weight history, current medications, lab work (if needed), and a baseline InBody body composition scan.

If tirzepatide is appropriate, I’ll prescribe the medication and provide injection training. It’s a once-weekly subcutaneous injection using a pre-filled pen, similar to an insulin pen. Patients start at a low dose (2.5 mg) and gradually increase every 4 weeks to minimize side effects and allow the body to adjust.

Weekly or biweekly InBody scans track progress, not just pounds lost, but changes in body fat percentage, muscle mass, and visceral fat. This provides a much clearer picture of metabolic improvement than the scale alone. My team and I provide ongoing support, including nutrition guidance, lifestyle coaching, and medication adjustments based on how each patient responds.

Many patients stay on tirzepatide long-term to maintain their results. The SURMOUNT-4 trial showed that discontinuing the medication leads to weight regain in many cases. JAMA 2024

One Patient’s Experience

As a physician, I know that seeing real results matters more than reading about possibilities. One of my patients in the Spring area recently shared her experience after starting weight loss injections at Harmony Aesthetics Spa.

Individual results may vary.

Bobbie’s response reflects what I often observe when we match the right intervention to a patient’s specific metabolic profile and treatment history. Not every patient sees improvement this quickly, but stories like Bobbie’s remind me why physician-guided medical weight loss programs matter.

Conclusion

Tirzepatide represents a major advancement in obesity medicine because it produces substantial, sustained weight loss by addressing the hormonal and metabolic factors that make long-term weight management so difficult.

Clinical trial data shows average weight loss of 15–21% at 72 weeks, with results that continue when treatment continues and regain when it stops. N Engl J Med 2022 JAMA 2024 This confirms that obesity is a chronic condition that requires ongoing medical management, not a short-term problem solved by willpower alone.

At Harmony Aesthetics Spa, I provide physician-supervised tirzepatide treatment with the clinical oversight, body composition monitoring, and lifestyle support that turn clinical trial results into real-world success. If you’re ready to explore whether tirzepatide is right for you, schedule a consultation at our Spring location serving patients throughout the greater North Houston area.

Frequently Asked Questions